These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 23549167)
41. Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer. Halbrook CJ; Lyssiotis CA Cancer Cell; 2017 Jan; 31(1):5-19. PubMed ID: 28073003 [TBL] [Abstract][Full Text] [Related]
42. Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer. Yamasaki A; Nakayama K; Imaizumi A; Kawamoto M; Fujimura A; Oyama Y; Nagai S; Yanai K; Onishi H Anticancer Res; 2017 Dec; 37(12):6649-6654. PubMed ID: 29187440 [TBL] [Abstract][Full Text] [Related]
43. Nox4-derived ROS signaling contributes to TGF-β-induced epithelial-mesenchymal transition in pancreatic cancer cells. Hiraga R; Kato M; Miyagawa S; Kamata T Anticancer Res; 2013 Oct; 33(10):4431-8. PubMed ID: 24123012 [TBL] [Abstract][Full Text] [Related]
44. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway. Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271 [TBL] [Abstract][Full Text] [Related]
45. Vasohibin 2 promotes malignant behaviors of pancreatic cancer cells by inducing epithelial-mesenchymal transition via Hedgehog signaling pathway. Zhang Y; Xue X; Zhao X; Qin L; Shen Y; Dou H; Sun J; Wang T; Yang DQ Cancer Med; 2018 Nov; 7(11):5567-5576. PubMed ID: 30318866 [TBL] [Abstract][Full Text] [Related]
46. Arginine deprivation inhibits pancreatic cancer cell migration, invasion and EMT via the down regulation of Snail, Slug, Twist, and MMP1/9. Wang H; Li QF; Chow HY; Choi SC; Leung YC J Physiol Biochem; 2020 Feb; 76(1):73-83. PubMed ID: 31823303 [TBL] [Abstract][Full Text] [Related]
47. Evaluating the Metabolic Impact of Hypoxia on Pancreatic Cancer Cells. Murthy D; Vernucci E; Goode G; Abrego J; Singh PK Methods Mol Biol; 2018; 1742():81-93. PubMed ID: 29330792 [TBL] [Abstract][Full Text] [Related]
48. The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance. Biancur DE; Kimmelman AC Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):67-75. PubMed ID: 29702208 [TBL] [Abstract][Full Text] [Related]
49. ARID1A, a SWI/SNF subunit, is critical to acinar cell homeostasis and regeneration and is a barrier to transformation and epithelial-mesenchymal transition in the pancreas. Wang W; Friedland SC; Guo B; O'Dell MR; Alexander WB; Whitney-Miller CL; Agostini-Vulaj D; Huber AR; Myers JR; Ashton JM; Dunne RF; Steiner LA; Hezel AF Gut; 2019 Jul; 68(7):1245-1258. PubMed ID: 30228219 [TBL] [Abstract][Full Text] [Related]
50. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
51. Epithelial and stromal expression of syndecan-2 in pancreatic carcinoma. Hrabar D; Aralica G; Gomercic M; Ljubicic N; Kruslin B; Tomas D Anticancer Res; 2010 Jul; 30(7):2749-53. PubMed ID: 20683009 [TBL] [Abstract][Full Text] [Related]
56. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763 [TBL] [Abstract][Full Text] [Related]
57. Conceptual framework for cutting the pancreatic cancer fuel supply. Le A; Rajeshkumar NV; Maitra A; Dang CV Clin Cancer Res; 2012 Aug; 18(16):4285-90. PubMed ID: 22896695 [TBL] [Abstract][Full Text] [Related]
58. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972 [TBL] [Abstract][Full Text] [Related]
59. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer. Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743 [TBL] [Abstract][Full Text] [Related]
60. Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer. Onishi H; Yamasaki A; Kawamoto M; Imaizumi A; Katano M Cancer Lett; 2016 Feb; 371(2):143-50. PubMed ID: 26655998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]